Status:
COMPLETED
Arthralgia During Anastrozole Therapy for Breast Cancer
Lead Sponsor:
AstraZeneca
Conditions:
Early Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to describe the joint symptoms and structural joint changes under anastrozole as adjuvant treatment in postmenopausal women with early breast cancer.
Eligibility Criteria
Inclusion
- Post menopausal woman with a breast cancer and scheduled for an adjuvant treatment with anastrozole
- WHO performance status 0, 1 or 2
- Provision of written informed consent
Exclusion
- Recurrence of breast cancer, inflammatory rheumatism
- treatment by chondromodulator, oral glucocorticoid, aromatase inhibitor, anti estrogen, Herceptin
- Diabetes treated by insulin
- Severe renal or hepatic disease
- Known hypersensitivity to anastrozole
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT00323479
Start Date
June 1 2006
End Date
January 1 2009
Last Update
April 6 2012
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Bordeaux, France
2
Research Site
Caen, France
3
Research Site
Lyon, France
4
Research Site
Paris, France